The Patent Finder

Terms ending in 2030

Abbott Laboratories

Every in-force patent on Abbott Laboratories's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,546,410Heteroaryl-Fused Macrocyclic Pyrimidine Derivatives
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,394,363Antibodies to Receptor of Advanced Glycation End Products (RAGE) and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,035,027Dual Variable Domain Immunoglobulins and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,420,081Antibody Formulations and Methods of Making Same
In force
 · High confidence
AbbVie Biotechnology Ltd.In forceHigh confidence
US 8,093,396Benzthiazole Inhibitors of Poly(ADP-RIBOSE)polymerase
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,283,162Antibodies Relating to Pivkaii and Uses Thereof
In force
 · High confidence
Abbott Japan LLCIn forceHigh confidence
US 8,120,485Articles Containing Chipless Radio Frequency Identification Elements
In force
 · High confidence
Abbott LaboratoriesIn forceHigh confidence
US 9,398,947Stent Graft
In force
 · Medium confidence
Bentley Innomed GmbHIn forceMedium confidence
US D751,215Container
In force
 · High confidence
Abbott LaboratoriesIn forceHigh confidence
US 9,353,091Antiviral Compounds and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
46 more term ends in 2030 · Pro
10 of 56 patents shown. Soonest term end first, then patent number.
Pro members see all 56.
Upgrade to Pro
14 of these are in force and held by Abbott Laboratories.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited